[Federal Register: August 22, 2003 (Volume 68, Number 163)]
[Notices]
[Page 50778-50782]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22au03-81]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 04011]
Grants for Injury Control Research Centers; Notice of
Availability of Funds
Application Deadline: September 22, 2003.
A. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under sections 301(a) and 391(a) of the
Public Health Service Act, (42 U.S.C. sections 280b(a) and 391(a)), as
amended. The Catalog of Federal Domestic Assistance number is 93.136.
B. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2004 funds for grants for Injury
Control Research Centers (ICRC). This program addresses the ``Healthy
People 2010'' focus area of Injury and Violence Prevention. A copy of
``Healthy People 2010'' is available at the following Internet address:
http://www.health.gov/healthypeople.
The purposes of this program are:
1. To support injury prevention and control research on priority
issues as delineated in: ``Healthy People 2010''; ``Reducing the Burden
of Injury: Advancing Prevention and Treatment''; and the research
priorities published in the CDC Injury Research Agenda, located at
http://www.cdc.gov/ncipc.
2. To integrate, in the context of a national program, the
disciplines of epidemiology, medicine, biomechanics and other
engineering, biostatistics, public health, law and criminal justice,
and behavioral and social sciences in order to prevent and control
injuries more effectively.
3. To define the injury problem; identify risk and protective
factors; develop and evaluate prevention and control interventions and
strategies; and ensure widespread adoption of effective interventions
and strategies.
4. To provide technical assistance to injury prevention and control
programs within a geographic region.
Measurable outcomes of the program will be in alignment with the
following performance goal for the National Center for Injury
Prevention and Control (NCIPC): Develop new or improved approaches for
preventing and controlling death and disability due to injuries.
C. Eligible Applicants
This announcement will provide funding for applicants in regions
that do not have funded Injury Control Research Centers (ICRCs) and for
applicants in regions that have funded Centers that must re-compete for
funding.
Eligible applicants include nonprofit and for-profit organizations.
Thus, universities, colleges, research institutions, hospitals, other
public and private organizations, faith-based organizations, tribal
organizations, State, Tribal, and local health departments, and small,
minority and/or women-owned businesses are eligible for these grants.
Non-academic applicant institutions should provide evidence of a
collaborative relationship with an academic institution.
Eligible applicants are limited to organizations in Department of
Health and Human Services (DHHS) Region II (New Jersey, New York,
Puerto Rico, and Virgin Islands), Region III (Delaware, District of
Columbia, Maryland, Pennsylvania, Virginia, and West Virginia), Region
IV (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina,
South Carolina, and Tennessee), Region VI (Arkansas, Louisiana, New
Mexico, Oklahoma, and Texas), Region IX (Arizona, California, Hawaii,
Nevada, American Samoa, Guam, Mariana Islands, Marshall Islands,
Micronesia, and Palau), and Region X (Alaska, Idaho, Oregon, and
Washington).
Note: ICRC grant awards are made to the applicant institution/
organization, not the Principal Investigator. Title 2 of the United
States Code section 1611 states that an organization described in
section 501(c)(4) of the Internal Revenue Code that engages in
lobbying activities is not eligible to receive Federal funds
constituting an award, grant or loan.
B. Funding
Availability of Funds
Approximately $4,527,500 is expected to be available in FY 2004 to
fund five awards. It is expected that each award will be $905,500
(total of direct and indirect costs). Applicants will be allowed to
apply for $1,055,500 ($150,000 above the expected award amount to allow
for the inclusion of the description of an additional large project as
described in Section F. Content 4.b. (2).), but each award will be no
more than $905,500 (total of direct and indirect costs). It is expected
that each award will begin on or about September 1, 2004, and will be
made for a 12-month budget period within a project period of up to five
years. Applications that exceed the funding cap noted above will be
excluded from the competition and returned to the applicant. Funding
estimates may change.
Consideration will also be given to current grantees that submit a
competitive supplement requesting one year of funding to enhance or
expand existing projects, or to conduct one-year pilot studies. These
awards will not exceed $150,000, including both direct and indirect
costs. Supplemental awards will be made for the budget period to
coincide with the actual budget period of the grant and are based on
the availability of funds.
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
Use of Funds
Center funding is to be designated for two types of activities. One
type of activity is considered core and includes administration,
management, general support services (e.g., statistical, library, media
relations, and advocacy) as well as activities associated with research
development, technical assistance, and education (e.g., seed projects,
training activities, and collaborative and technical assistance
activities with other groups). Funds may be allocated for trainee
stipends, tuition remission, and trainee travel in accordance with the
current rates for the United States Public Health Service agencies.
Indirect costs for these trainee-related activities are limited to
eight percent.
Defined research projects constitute the second type of activity,
and ICRCs are encouraged to work toward addressing the breadth of the
field. Core activities and defined research projects may each
constitute between 25 percent and 75 percent of the operating budget,
and should be balanced in such a way that the ICRC demonstrates
productivity in research as well as teaching and service. Applicants
with less demonstrated expertise in research are encouraged to devote a
larger percentage of funds to defined research projects in order to
establish their capability as research centers of excellence.
Grant funds will not be made available to support the provision of
direct care. Studies may be supported
[[Page 50779]]
which evaluate methods of acute care and rehabilitation for potential
reductions in injury effects and costs. Studies may be supported which
identify the effect on injury outcomes and cost of systems for pre-
hospital, hospital, and rehabilitative care and independent living.
Eligible applicants may enter into contracts, including consortia
agreements (as set forth in the PHS Grants Policy Statement, dated
April 1, 1994), as necessary to meet the requirements of the program
and strengthen the overall application.
Funding Preferences
At the discretion of the Director, NCIPC, additional consideration
may be given to re-competing ICRCs. These centers represent a long-term
investment for NCIPC and an established resource for injury control-
related issues for their States and regions.
Recipient Financial Participation
Matching funds are not required for this program announcement,
however other sources of funding must be documented.
E. Program Requirements
In conducting activities to achieve the purpose of this program,
applicants will be responsible for the following activities.
1. Applicants must demonstrate expertise and experience in
conducting and publishing injury research in at least one of the three
phases of injury control (prevention, acute care, or rehabilitation)
and are encouraged to be comprehensive.
2. Applicants must document ongoing injury control-related research
projects and activities currently supported by other sources of
funding.
3. Applicants must provide a director (Principal Investigator) who
has specific authority and responsibility to carry out the project. The
director must report to an appropriate institutional official, e.g.,
dean of a school, vice president of a university, or commissioner of
health. The director must have no less than thirty percent effort
devoted solely to this project with an anticipated range of thirty
percent to fifty percent.
4. Applicants must provide evidence of working relationships,
including consultation and technical assistance, with outside agencies
and other entities in the region in which the ICRC is located which
will allow for implementation and evaluation of any proposed
intervention activities.
5. Applicants must provide evidence of involvement of specialists
or experts in medicine, biomechanics and other engineering,
epidemiology, law and criminal justice, behavioral and social sciences,
biostatistics, and public health as needed to complete the plans of the
center. These are considered the disciplines and fields for ICRCs.
6. Applicants must have established curricula and graduate training
programs in disciplines relevant to injury control (See Section E.5).
7. Applicants must disseminate injury control research findings,
translate them into interventions (i.e., programs or policies), and
evaluate their effectiveness.
F. Content
Letter of Intent (LOI)
A LOI is strongly encouraged for this program. The program
announcement title and number must appear in the LOI. The narrative
should be no more than two single-spaced pages, printed on one side,
with one-inch margins, and unreduced 12-point font. The letter should
identify the name of the principal investigator, and briefly describe
the scope and intent of the proposed research work. The letter of
intent does not influence review or funding decisions, but the number
of letters received will enable CDC to plan the review more effectively
and efficiently.
Application
The Program Announcement title and number must appear in the
application. Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Applications should include the following
information, detailing activities to be conducted for the first budget
year, while briefly addressing activities to be conducted over the
entire five-year project period.
1. Face page
2. Description (abstract) and personnel
3. Table of contents
4. Detailed budget for the initial budget period: The budget should
reflect the composite figures for the grant. In addition, separate
budgets (direct and indirect costs) and justifications should be
provided for the following categories of activities:
a. Core activities, including management and administrative
functions, other non-research activities (e.g., education/training,
consultation, technical assistance, translation/dissemination, program
and policy development and evaluation, advocacy, and media activities,
etc.), and small seed projects of less than $25,000 (total of direct
and indirect costs) for one year or less.
b. Research Studies:
(1) Small studies of $25,000-150,000/year (total of direct and
indirect costs) for one to three years duration. These projects might
be expansions of seed projects, either further developing methods or
hypotheses in preparation for a larger investigation leading to the
submission of an RO1 level proposal, or might be stand-alone
investigations sufficient to yield results worthy of publication in a
peer-reviewed journal and/or a technical report for a legislative body,
governmental agency, or injury control program.
(2) Larger scale studies with annual budgets exceeding $150,000/
year (total of direct and indirect costs) and lasting up to five years.
These projects typically will test hypotheses and employ more
sophisticated methodologies and/or larger sample sizes than small
studies.
For seed projects, only modest budget descriptions are required
within the application. More detailed budget descriptions, commensurate
with costs, are required for both small studies and large research
projects.
An applicant organization has the option of having specific salary
and fringe benefit amounts for individuals omitted from the copies of
the application that are made available to outside reviewing groups. To
exercise this option: on the original and two copies of the
application, the applicant must use asterisks to indicate those
individuals for whom salaries and fringe benefits are not shown; the
subtotals must still be shown. In addition, the applicant must submit
an additional copy of page four of Form PHS-398, completed in full,
with the asterisks replaced by the salaries and fringe benefits. This
budget page will be reserved for internal staff use only.
5. Budget for entire proposed project period including budgets
pertaining to consortium/contractual arrangements.
6. Biographical sketches of key personnel, consultants, and
collaborators, beginning with the Principal Investigator and core
faculty.
7. Other support: This listing should include all other funds or
resources pending or currently available. For each grant or contract
include source of funds, amount of funding (indicate whether pending or
current), date of funding (initiation and termination), and
relationship to the proposed program.
8. Resources and environment.
9. Research plan:
a. ICRCs are to develop a range of research and other non-research
[[Page 50780]]
activities that are designed to advance the field of injury control
through development of new scientific or surveillance methods, creation
of new knowledge, and translation of knowledge into training, program
and policy development and evaluation activities or other applications
that will ultimately reduce injuries or their effects. ICRC
applications should articulate how the activities of their program are
integrated with each other.
b. A detailed research plan (design and methods), in accordance
with NCIPC's performance goal as stated in section ``B. Purpose'',
including hypothesis, expected outcome, value to the field, and
measurable and time-framed objectives consistent with the activities
for each project within the proposed grant.
(1) Initial seed projects require a short write-up describing the
injury control context of the study, the objective, the design, the
setting and participants, the intervention being addressed, main
outcome measurements, expected results, time lines, cost (total of
direct and indirect costs), plans for translation/dissemination, and
clear definition of procedures used to select the projects. Clear
definitions of procedures used to select future out-year seed projects
are also required.
(2) Small research projects require a ten to fifteen page summary
describing the accomplishment of all the steps, including a description
of the significance of the project, the development and testing of
methods and instruments, and the collection of preliminary data needed
to take an innovative approach and develop it to the level of a larger
investigation leading to the submission of an RO1 level proposal or a
stand-alone investigation sufficient to yield results worthy of
publication in a peer-reviewed journal and/or a technical report for a
legislative body, governmental agency, or injury control program.
(3) Large research projects require an RO1 level summary as
described in the PHS 398 (Revised 5/01 and updated 6/28/02) guidelines
(See Attachment 2, as posted on the CDC website). The summary should be
included as an appendix of the application.
In the research plan section of the application include a
description for each small and large research project:
(a) Title of Project
(b) Project Director/Lead Investigator
(c) Institution(s)
(d) Categorization as Prevention, Acute Care, Rehabilitation, or
Biomechanics
(e) Categorization as to which NCIPC research agenda priority area
the project addresses. Also, a brief description on how it addresses
that priority area. If a priority area is not addressed, provide an
explanation of why it is important.
(f) Categorization as Seed Project, Small Project, or Large Project
(g) Categorization as New or Ongoing Project
(h) Cost/Year (total of direct and indirect costs)
(i) Research Training: Names, Degrees of Persons Trained or in
Training
(j) Key Words
(k) Brief Summary of Project including Intended Application of
Finding (Abstract)
c. A description of the core faculty and their roles in
implementing and evaluating the proposed programs. The applicant should
clearly specify how disciplines will be integrated to achieve the ICRCs
objectives.
d. Charts showing the proposed organizational structure of the ICRC
and its relationship to the broader institution of which it is a part
and, where applicable, to affiliate institutions or collaborating
organizations. These charts should clearly detail the lines of
authority as they relate to the center, both structurally and
operationally. ICRC directors should report to an appropriate
organizational level (e.g. dean of a school, vice president of a
university, or commissioner of health), demonstrating strong
institution-wide support of ICRC activities and ensuring oversight of
the process of interdisciplinary activity.
e. Documentation of the public health agencies and other public and
private sector entities to be involved in the proposed program,
including letters that detail commitments of support and a clear
statement of the role, activities, and participating personnel of each
agency or entity.
Beginning October 1, 2003, applicants will be required to have a
Dun and Bradstreet (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge.
You are encouraged to obtain a DUNS now if you believe you will be
submitting an application to any Federal agency on or after October 1,
2003. Proactively obtaining a DUNS number at the current time will
facilitate the receipt and acceptance of applications after September
2003.
To obtain a DUNS number, access the following web site:
www.dunandbradstreet.com OR call 1-866-705-5711.
G. Submission and Deadline
Letter of Intent (LOI) Submission
On or before September 8, 2003, submit the LOI to the Grants
Management Specialist identified in the ``Where to Obtain Additional
Information'' section of this announcement.
Application Forms
Submit the original and two copies of PHS 398 (OMB Number 0925-
0001) and one electronic disk copy and adhere to the instructions on
the Errata Instruction sheet for PHS 398. Forms are available at the
following Internet address: www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
at: 770-488-2700. Application forms can be mailed to you.
Submission Date, Time, and Address
The application must be received by 4:00 p.m. Eastern Time,
November 20, 2003. Submit the application to: Technical Information
Management Section-PA04011-CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, Georgia 30341. Applications may not be
submitted electronically.
CDC Acknowledgment of Application Receipt
A postcard will be mailed by PGO-TIM, notifying you that CDC has
received your application.
Deadline
Letters of intent and applications shall be considered as meeting
the deadline if they are received before 4 p.m. Eastern Time on the
deadline date. Applicants sending applications by the United States
Postal Service or commercial delivery services must ensure that the
carrier will be able to guarantee delivery of the application by the
closing date and time. If an application is received after closing due
to (1) carrier error, when the carrier accepted the package with a
guarantee for delivery by the closing date and time, or (2) significant
weather delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
Any application that does not meet the above criteria will not be
eligible for competition, and will be discarded. The applicant will be
notified of their failure to meet the submission requirements.
[[Page 50781]]
A. Evaluation Criteria
Application
Applications will be reviewed by CDC staff for completeness and
responsiveness as outlined under the previous heading Program
Requirements. Incomplete applications and applications that are not
responsive will be returned to the applicant without further
consideration.
Applications which are complete and responsive will be subjected to
a preliminary evaluation (streamline review) by the Injury Research
Grant Review Committee (IRGRC) to determine if the application is of
sufficient technical and scientific merit to warrant further review by
the IRGRC. Applications that are determined noncompetitive will not be
considered, and NCIPC will promptly notify the investigator/program
director and the official signing for the applicant organization.
Applications determined to be competitive will be evaluated by a dual
review process.
Competing supplemental grant awards may be made, when funds are
available, to support research work or activities not previously
approved by the IRGRC. Applications should be clearly labeled to denote
their status as requesting supplemental funding support. These
applications will be reviewed by the IRGRC and the secondary review
group.
Awards will be made based on priority scores assigned to
applications by the IRGRC, programmatic priorities and needs determined
by a secondary review committee (the Advisory Committee for Injury
Prevention and Control), and the availability of funds.
1. Review by IRGRC
An initial streamline peer-review of ICRC grant applications will
be conducted by the IRGRC. The IRGRC may recommend the application for
a site visit review. For those applications recommended for a site
visit review, a team of peer reviewers, including members of the IRGRC,
will conduct on-site visits at each applicant institution, generate
summary statements for the visits, and report the assessment to the
IRGRC.
Factors to be considered by the IRGRC include:
a. The specific aims of the application, e.g., the long-term
objectives and intended accomplishments. Approval of small and large
research projects (including new research projects proposed during the
five-year funding cycle), in accordance with NCIPC's performance goal
as stated in section ``B. Purpose'', is subject to peer review.
(1) Seed projects will be evaluated collectively on the mechanism
for solicitation of projects and on their technical/scientific merit
review. Evaluation criteria have equal value.
(2) Small projects will be evaluated individually on the
significance of the project, the innovative approach, and the proposed
methods for achieving an investigation sufficient to support a
submission of an RO1 level proposal and/or worthy of publication in a
peer-reviewed journal and/or a technical report for a legislative body,
governmental agency, or injury control program.
(3) Large projects will be evaluated individually according to
existing RO1 level project standards as described in the PHS 398
(Revised 5/01 and updated 6/28/02) guidelines (See Attachment 2, as
posted on the CDC website). The application must have a minimum of one
large research project approved in order to be recommended for further
consideration.
(4) At least 80 percent of the costs (total direct and indirect
costs) of the approved small and large research projects must be in
alignment with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc
in order to be recommended for further consideration.
b. The scientific and technical merit of the overall application,
including the significance and originality (e.g., new topic, new
method, new approach in a new population, or advancing understanding of
the problem) of the proposed research.
c. The extent to which the evaluation plan will allow for the
measurement of progress toward the achievement of stated objectives.
Does the application specify how the effectiveness of the program will
be measured?
d. Qualifications, adequacy, and appropriateness of personnel to
accomplish the proposed activities.
e. The soundness of the proposed budget in terms of adequacy of
resources and their allocation.
f. In addition to conducting defined research projects, ICRCs are
expected to devote substantial attention to advancing the field through
other activities that are designed to improve research capabilities and
translate research into practice. Examples of activities include:
consultation and technical assistance that are responsive to regional,
State, national, or international priorities; professional training for
researchers and practitioners; program development; and evaluation
endeavors. The degree of effort devoted to these aspects of an ICRCs
program should be clearly stated in the justification and the budget.
The degree of effort may be varied and should reflect the specific
focus and goals of the ICRC.
g. Details of progress in the most recent funding period should be
provided in the application if the applicant is submitting a re-
competing application. Documented examples of success include:
development of pilot projects; completion of high quality research
projects; publication of findings in peer reviewed scientific and
technical journals; number of professionals trained; awards received;
ongoing provision of consultation and technical assistance; integration
of disciplines; translation of research into implementation; and impact
on injury control outcomes including legislation, regulation,
treatment, and behavior modification interventions.
h. Does the application adequately address the requirements of
Title 45 CFR Part 46 for the protection of human subjects?
i. Does the applicant meet the CDC Policy requirements regarding
the inclusion of women, ethnic, and racial groups in the proposed
research? This includes:
(1) The proposed plan for the inclusion of both sexes, racial and
ethnic minority populations for appropriate representation.
(2) The proposed justification when representation is limited or
absent.
(3) A statement as to whether the design of the study is adequate
to measure differences when warranted.
(4) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community or communities and recognition of mutual
benefits.
j. Does the application adequately address the requirements of the
``PHS Policy on Humane Care and Use of Laboratory Animals by Awardee
Institutions?''
k. Does the application include measures that are in accordance
with CDC's performance plans?
2. Review by the CDC Advisory Committee for Injury Prevention and
Control (ACIPC)
Secondary review of ICRC grant applications with a priority score
of 350 or better from the initial peer-review by the IRGRC will be
conducted by the Science and Program Review Section (SPRS) of the
ACIPC. The SPRS consists of ACIPC members, Federal Ex Officio
participants, and organizational liaisons. The Federal Ex Officio
participants will be responsible for
[[Page 50782]]
identifying proposals in overlapping areas of research interest so that
unwarranted duplication in federally funded research can be avoided.
The NCIPC Division Associate Directors for Science (ADS) or their
designees will address the SPRS to assure that research priorities of
the announcement are understood and to provide background regarding
current research activities. The SPRS recommendations will be presented
to the entire ACIPC in the form of a report by the Chairman of the
SPRS. The ACIPC will vote to approve, disapprove, or modify these
recommendations for funding consideration.
Factors to be considered by the ACIPC include:
a. The results of the peer-review.
b. The significance of the proposed activities as they relate to
national program priorities, geographic balance, and the achievement of
national objectives.
c. The overall balance of the ICRC program in addressing the three
phases of injury control (prevention, acute care, and rehabilitation);
the control of injury among populations who are at increased risk,
including racial/ethnic minority groups, the elderly and children; the
major causes of intentional and unintentional injury; and the major
disciplines of injury control.
d. Budgetary considerations. The ACIPC will recommend annual
funding levels as detailed in section ``D. Funds'' of this
announcement.
These recommendations, based on the results of the peer review by
the IRGRC, the relevance and balance of the proposed research relative
to the NCIPC programs and priorities, and the assurance of no
duplication of federally-funded research, are presented to the
Director, NCIPC, for funding decisions.
3. Continued Funding
Continuation awards within the project period will be made on the
basis of the availability of funds and the following criteria:
a. The accomplishments of the current budget period show that the
applicant's objectives as prescribed in the yearly work plans are being
met.
b. The objectives for the new budget period are realistic,
specific, and measurable.
c. The methods described will clearly lead to achievement of these
objectives.
d. The evaluation plan allows management to monitor whether the
methods are effective by having clearly defined process, impact, and
outcome objectives, and the applicant demonstrates progress in
implementing the evaluation plan.
e. The budget request is clearly explained, adequately justified,
reasonable, and consistent with the intended use of grant funds.
I. Other Requirements
Technical Reporting Requirements
Provide CDC with the original plus two copies of:
1. Annual progress report. The progress report will include a data
requirement that demonstrates measures of effectiveness.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final financial status report and performance report, no more
than 90 days after the end of the project period.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
The following additional requirements are applicable to this
program. For a complete description of each, see Attachment 1 of this
announcement as posted on the CDC home Web site.
AR-1 Human Subjects Certification
AR-2 Requirements for inclusion of Women and Racial and Ethnic
Minorities in Research
AR-3 Animal Subjects Requirements
AR-10 Smoke-Free Workplace Requirement
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC funds for Certain Gun Control
Activities
AR-20 Conference Activities within Grants/Cooperative Agreements
AR-21 Small, Minority, and Women-owned Business
AR-22 Research Integrity
Executive Order 12372 does not apply to this program.
J. Where To Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address--http://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements''.
For general questions about this announcement, contact: Technical
Information Management, CDC Procurement and Grants Office, 2920
Brandywine Rd Atlanta, GA 30341-4146, Telephone: 770-488-2700.
For business management and budget assistance, contact: Nancy
Pillar, Grants Management Specialist, CDC Procurement and Grants Office
2920 Brandywine Rd, Atlanta, GA 30341-4146, Telephone: 770-488-2721, E-
mail: nfp6@cdc.gov. For business management and budget assistance in the territories,
contact:
Charlotte Flitcraft, CDC Procurement and Grants Office 2920
Brandywine Rd., Atlanta, GA 30341-4146, Telephone: 770-488-2780, E-
mail: caf5@cdc.gov. For program technical assistance, contact: Tom Voglesonger, Program
Manager, Office of the Associate Director for Science, National Center
for Injury Prevention and Control, Centers for Disease Control and
Prevention (CDC), 4770 Buford Highway, NE., (K58), Atlanta, GA 30341-
3724, Telephone: 770-488-4823, E-mail: tdv1@cdc.gov.
Dated: August 18, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 03-21514 Filed 8-21-03; 8:45 am]
BILLING CODE 4163-18-P